RE-BVS – Piemonte Repository

Sfoglia per AUTORE
RANDON G
Collezione AOU San Luigi di Orbassano

Items : 5

Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial. in The Lancet. Oncology

2024
AOU San Luigi di Orbassano

Randon G; Lonardi S; Fassan M; Palermo F; Tamberi S; Giommoni E; Ceccon C; Di Donato S; Fornaro L; Brunetti O; De Vita F; Bittoni A; Chini C; Spallanzani A; Nappo F; Bethaz V; Strippoli A; Latiano T; Cardellino GG; Giuliani F; Morano F; Niger M; Raimondi A; Prisciandaro M; Pircher CC; Sciortino C; Marchesi S; Garattini SK; Airò G; et alii...

Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial. in BMC cancer / BMC Cancer. 2023 Sep 26;23(1):908. doi: 10.1186/s12885-023-11287-2.

2023
AOU San Luigi di Orbassano

Corti F; Brizzi MP; Amoroso V; Giuffrida D; Panzuto F; Campana D; Prinzi N; Milione M; Cascella T; Spreafico C; Randon G; Oldani S; Leporati R; Scotto G; Pulice I; Stocchetti BL; Porcu L; Coppa J; Di Bartolomeo M; de Braud F; Pusceddu S;

Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial. in International journal of cancer / Int J Cancer. 2022 Nov 15;151(10):1760-1769. doi: 10.1002/ijc.34156. Epub 2022 Jun 23.

2022
ASL Torino 4
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Morano F; Pietrantonio F; Di Maio M; Di Bartolomeo M; Antonuzzo L; Giordano M; Rossi A; Ratti M; Petrelli F; Berenato R; Clavarezza M; Zaniboni A; Fanchini L; Murialdo R; Sartore-Bianchi A; Tampellini M; Bozzarelli S; Antoniotti C; Lonardi S; Pagani F; Prisciandaro M; Randon G; Raimondi A;

Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2021 Jul;29(7):3971-3980. doi: 10.1007/s00520-020-05972-2. Epub 2021 Jan 3.

2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Morano F; Pietrantonio F; Di Bartolomeo M; de Braud F; Randon G; Prisciandaro M; Pagani F; Ambrosini M; Antista M; Niger M; Longarini R; Cinieri S; Giordano M; Antonuzzo L; Petrelli F; Tomasello G; Toscano G; Zaniboni A; Clavarezza M; Murialdo R; Racca P; Tampellini M; Amatu A; Rimassa L; Lonardi S; Antoniotti C; Corallo S; Raimondi A;

Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Feb;144:31-40. doi: 10.1016/j.ejca.2020.11.017. Epub 2020 Dec 13.

2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Morano F; Pietrantonio F; Calareso G; de Braud F; Di Bartolomeo M; Vaiani M; Greco FG; Palermo F; Pagani F; Prisciandaro M; Raimondi A; Racca P; Antista M; Clavarezza M; Tomasello G; Tampellini M; Zaniboni A; Murialdo R; Smiroldo V; Antoniotti C; Bergamo F; Rimassa L; Lonardi S; Cremolini C; Randon G; Corallo S; Manca P;